These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
215 related articles for article (PubMed ID: 32066429)
1. Overcoming cisplatin resistance by targeting the MTDH-PTEN interaction in ovarian cancer with sera derived from rats exposed to Guizhi Fuling wan extract. Han L; Cao X; Chen Z; Guo X; Yang L; Zhou Y; Bian H BMC Complement Med Ther; 2020 Feb; 20(1):57. PubMed ID: 32066429 [TBL] [Abstract][Full Text] [Related]
2. Guizhi Fuling Wan, a Traditional Chinese Herbal Formula, Sensitizes Cisplatin-Resistant Human Ovarian Cancer Cells through Inactivation of the PI3K/AKT/mTOR Pathway. Han L; Guo X; Bian H; Yang L; Chen Z; Zang W; Yang J Evid Based Complement Alternat Med; 2016; 2016():4651949. PubMed ID: 27293459 [TBL] [Abstract][Full Text] [Related]
3. Cisplatin-induced caspase activation mediates PTEN cleavage in ovarian cancer cells: a potential mechanism of chemoresistance. Singh M; Chaudhry P; Fabi F; Asselin E BMC Cancer; 2013 May; 13():233. PubMed ID: 23663432 [TBL] [Abstract][Full Text] [Related]
4. PTEN overexpression improves cisplatin-resistance of human ovarian cancer cells through upregulating KRT10 expression. Wu H; Wang K; Liu W; Hao Q Biochem Biophys Res Commun; 2014 Feb; 444(2):141-6. PubMed ID: 24434152 [TBL] [Abstract][Full Text] [Related]
5. Guizhi Fuling Wan, Chinese Herbal Medicine, Ameliorates Insulin Sensitivity in PCOS Model Rats With Insulin Resistance via Remodeling Intestinal Homeostasis. Zhu Y; Li Y; Liu M; Hu X; Zhu H Front Endocrinol (Lausanne); 2020; 11():575. PubMed ID: 32973686 [TBL] [Abstract][Full Text] [Related]
6. Potential Mechanisms of Guizhi Fuling Wan in Treating Endometriosis: An Analysis Based on TCMSP and DisGeNET Databases. Yee JL; Huang CY; Yu YC; Huang SJ J Ethnopharmacol; 2024 Jul; 329():118190. PubMed ID: 38614264 [TBL] [Abstract][Full Text] [Related]
7. [Effect of MTRR gene on apoptosis and autophagy pathways in multiresistant epithelial ovarian cancer]. Chen J; Wang Q; Zhang W; Li L Zhonghua Fu Chan Ke Za Zhi; 2016 Apr; 51(4):285-92. PubMed ID: 27116987 [TBL] [Abstract][Full Text] [Related]
8. MTDH mediates trastuzumab resistance in HER2 positive breast cancer by decreasing PTEN expression through an NFκB-dependent pathway. Du C; Yi X; Liu W; Han T; Liu Z; Ding Z; Zheng Z; Piao Y; Yuan J; Han Y; Xie M; Xie X BMC Cancer; 2014 Nov; 14():869. PubMed ID: 25417825 [TBL] [Abstract][Full Text] [Related]
9. A Chinese classical prescription Guizhi-Fuling Wan in treatment of ovarian cancer: An overview. Wang X; Su P; Hao Q; Zhang X; Xia L; Zhang Y Biomed Pharmacother; 2022 Sep; 153():113401. PubMed ID: 36076526 [TBL] [Abstract][Full Text] [Related]
10. [Establishment and biological characteristics of a platinum-resistance nude mouse model in epithelial ovarian cancer]. Shi L; Yu H; Zhang W; Li L; Wang Q Zhonghua Fu Chan Ke Za Zhi; 2014 Jul; 49(7):523-30. PubMed ID: 25327735 [TBL] [Abstract][Full Text] [Related]
11. [Reversal of drug resistance in human ovarian cancer cells by wild-type PTEN gene and its mechanisms]. Wu HJ; Wu HT; Weng DH; Xing H; Lu YP; Ma D Zhonghua Fu Chan Ke Za Zhi; 2007 Sep; 42(9):612-6. PubMed ID: 17983517 [TBL] [Abstract][Full Text] [Related]
12. [Regulatory effects and associated mechanisms of miR-130a molecules on cisplatin resistance in ovarian cancer A2780 cell lines]. Li NW; Wang HJ; Yang LY; Jia XB; Chen C; Wang X Sichuan Da Xue Xue Bao Yi Xue Ban; 2013 Nov; 44(6):865-70. PubMed ID: 24490491 [TBL] [Abstract][Full Text] [Related]
13. Roles of microRNA-22 in Suppressing Proliferation and Promoting Sensitivity of Osteosarcoma Cells via Metadherin-mediated Autophagy. Wang P; Zhao ZQ; Guo SB; Yang TY; Chang ZQ; Li DH; Zhao W; Wang YX; Sun C; Wang Y; Feng W Orthop Surg; 2019 Apr; 11(2):285-293. PubMed ID: 30932352 [TBL] [Abstract][Full Text] [Related]
14. MTDH/AEG-1 downregulation using pristimerin-loaded nanoparticles inhibits Fanconi anemia proteins and increases sensitivity to platinum-based chemotherapy. Bi J; Areecheewakul S; Li Y; Yang S; Zhang Y; Ebeid K; Li L; Thiel KW; Zhang J; Dai D; Salem AK; Leslie KK; Meng X Gynecol Oncol; 2019 Nov; 155(2):349-358. PubMed ID: 31477281 [TBL] [Abstract][Full Text] [Related]
15. [ Guo X; Chen L; Lü Q; DU R; Luo Q; Zhang Y; Bian H; Han L Nan Fang Yi Ke Da Xue Xue Bao; 2023 Aug; 43(8):1315-1321. PubMed ID: 37712267 [TBL] [Abstract][Full Text] [Related]
16. [Effect and mechanism of endoplasmic reticulum stress on cisplatin resistance in ovarian carcinoma]. Tian J; Hu X; Qu Q Zhonghua Zhong Liu Za Zhi; 2014 May; 36(5):324-8. PubMed ID: 25030585 [TBL] [Abstract][Full Text] [Related]
17. MiR-130a and MiR-374a Function as Novel Regulators of Cisplatin Resistance in Human Ovarian Cancer A2780 Cells. Li N; Yang L; Wang H; Yi T; Jia X; Chen C; Xu P PLoS One; 2015; 10(6):e0128886. PubMed ID: 26043084 [TBL] [Abstract][Full Text] [Related]
18. Phosphatase and Tensin Homolog Is a Potential Target for Ovarian Cancer Sensitization to Cytotoxic Agents. McCormick A; Earp E; Leeson C; Dixon M; O'Donnell R; Kaufmann A; Edmondson RJ Int J Gynecol Cancer; 2016 May; 26(4):632-9. PubMed ID: 26905328 [TBL] [Abstract][Full Text] [Related]
19. Long non-coding RNA Linc00312 modulates the sensitivity of ovarian cancer to cisplatin via the Bcl-2/Caspase-3 signaling pathway. Zhang C; Wang M; Shi C; Shi F; Pei C Biosci Trends; 2018 Jul; 12(3):309-316. PubMed ID: 29952351 [TBL] [Abstract][Full Text] [Related]
20. Noscapine Increases the Sensitivity of Drug-Resistant Ovarian Cancer Cell Line SKOV3/DDP to Cisplatin by Regulating Cell Cycle and Activating Apoptotic Pathways. Shen W; Liang B; Yin J; Li X; Cheng J Cell Biochem Biophys; 2015 May; 72(1):203-13. PubMed ID: 25510462 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]